SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908733-07-000245
Filing Date
2007-03-05
Accepted
2007-03-05 11:13:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INC 13GA1 ligandpharmaceutical.htm SC 13G/A 9377
  Complete submission text file 0000908733-07-000245.txt   11622
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 07669996
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000